462 related articles for article (PubMed ID: 15447669)
21. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters.
Shen HW; Hagino Y; Kobayashi H; Shinohara-Tanaka K; Ikeda K; Yamamoto H; Yamamoto T; Lesch KP; Murphy DL; Hall FS; Uhl GR; Sora I
Neuropsychopharmacology; 2004 Oct; 29(10):1790-9. PubMed ID: 15226739
[TBL] [Abstract][Full Text] [Related]
22. Age-related changes in nigrostriatal dopaminergic function in heterozygous mutant dopamine transporter knock-out mice.
Dluzen DE; Ji J; McDermott JL
Neurosci Lett; 2010 May; 476(2):66-9. PubMed ID: 20382201
[TBL] [Abstract][Full Text] [Related]
23. Release and uptake of catecholamines in the bed nucleus of the stria terminalis measured in the mouse brain slice.
Miles PR; Mundorf ML; Wightman RM
Synapse; 2002 Jun; 44(3):188-97. PubMed ID: 11954051
[TBL] [Abstract][Full Text] [Related]
24. Food-reinforced operant behavior in dopamine transporter knockout mice: enhanced resistance to extinction.
Hironaka N; Ikeda K; Sora I; Uhl GR; Niki H
Ann N Y Acad Sci; 2004 Oct; 1025():140-5. PubMed ID: 15542711
[TBL] [Abstract][Full Text] [Related]
25. Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference.
Thakker DR; Natt F; Hüsken D; Maier R; Müller M; van der Putten H; Hoyer D; Cryan JF
Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17270-5. PubMed ID: 15569935
[TBL] [Abstract][Full Text] [Related]
26. Effects of beta-phenylethylamine on dopaminergic neurons of the ventral tegmental area in the rat: a combined electrophysiological and microdialysis study.
Ishida K; Murata M; Katagiri N; Ishikawa M; Abe K; Kato M; Utsunomiya I; Taguchi K
J Pharmacol Exp Ther; 2005 Aug; 314(2):916-22. PubMed ID: 15879004
[TBL] [Abstract][Full Text] [Related]
27. Enhanced dopamine uptake in the striatum following repeated restraint stress.
Copeland BJ; Neff NH; Hadjiconstantinou M
Synapse; 2005 Sep; 57(3):167-74. PubMed ID: 15945060
[TBL] [Abstract][Full Text] [Related]
28. Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice.
Mori A; Ohashi S; Nakai M; Moriizumi T; Mitsumoto Y
Neurosci Res; 2005 Mar; 51(3):265-74. PubMed ID: 15710490
[TBL] [Abstract][Full Text] [Related]
29. Effect of dopamine uptake inhibition on brain catecholamine levels and locomotion in catechol-O-methyltransferase-disrupted mice.
Huotari M; Santha M; Lucas LR; Karayiorgou M; Gogos JA; Männistö PT
J Pharmacol Exp Ther; 2002 Dec; 303(3):1309-16. PubMed ID: 12438556
[TBL] [Abstract][Full Text] [Related]
30. The dopamine transporter: importance in Parkinson's disease.
Nutt JG; Carter JH; Sexton GJ
Ann Neurol; 2004 Jun; 55(6):766-73. PubMed ID: 15174010
[TBL] [Abstract][Full Text] [Related]
31. Selective alterations of gene expression in mice induced by MPTP.
Xu Z; Cawthon D; McCastlain KA; Slikker W; Ali SF
Synapse; 2005 Jan; 55(1):45-51. PubMed ID: 15499605
[TBL] [Abstract][Full Text] [Related]
32. A triple mutation in the second transmembrane domain of mouse dopamine transporter markedly decreases sensitivity to cocaine and methylphenidate.
Chen R; Han DD; Gu HH
J Neurochem; 2005 Jul; 94(2):352-9. PubMed ID: 15998286
[TBL] [Abstract][Full Text] [Related]
33. Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.
Carroll FI; Runyon SP; Abraham P; Navarro H; Kuhar MJ; Pollard GT; Howard JL
J Med Chem; 2004 Dec; 47(25):6401-9. PubMed ID: 15566309
[TBL] [Abstract][Full Text] [Related]
34. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
[TBL] [Abstract][Full Text] [Related]
35. Altered corticostriatal neurotransmission and modulation in dopamine transporter knock-down mice.
Wu N; Cepeda C; Zhuang X; Levine MS
J Neurophysiol; 2007 Jul; 98(1):423-32. PubMed ID: 17522168
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter.
Jones SR; Gainetdinov RR; Wightman RM; Caron MG
J Neurosci; 1998 Mar; 18(6):1979-86. PubMed ID: 9482784
[TBL] [Abstract][Full Text] [Related]
37. Comparison between intraperitoneal and oral methylphenidate administration: A microdialysis and locomotor activity study.
Gerasimov MR; Franceschi M; Volkow ND; Gifford A; Gatley SJ; Marsteller D; Molina PE; Dewey SL
J Pharmacol Exp Ther; 2000 Oct; 295(1):51-7. PubMed ID: 10991960
[TBL] [Abstract][Full Text] [Related]
38. Stimulation of postsynaptic alpha1b- and alpha2-adrenergic receptors amplifies dopamine-mediated locomotor activity in both rats and mice.
Villégier AS; Drouin C; Bizot JC; Marien M; Glowinski J; Colpaërt F; Tassin JP
Synapse; 2003 Dec; 50(4):277-84. PubMed ID: 14556232
[TBL] [Abstract][Full Text] [Related]
39. Covalent and noncovalent chemical modifications of arginine residues decrease dopamine transporter activity.
Volz TJ; Kim M; Schenk JO
Synapse; 2004 Jun; 52(4):272-82. PubMed ID: 15103693
[TBL] [Abstract][Full Text] [Related]
40. Neurochemical and behavioral responses to cocaine in adult male rats with neonatal isolation experience.
Kosten TA; Zhang XY; Kehoe P
J Pharmacol Exp Ther; 2005 Aug; 314(2):661-7. PubMed ID: 15845857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
